Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study

Immune-checkpoint inhibitors may provide long-term survival benefits via a cured proportion, yet data are usually insufficient to prove this upon submission to health technology assessment bodies.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research